Latest news

Otsuka continues its bet on autoimmune therapies with $613M Cantargia antibody deal

Otsuka continues its bet on autoimmune therapies with $613M Cantargia antibody deal

Joachim Eeckhout
WHO adds ArkBio ́s RSV drug to its priority list

WHO adds ArkBio ́s RSV drug to its priority list

Eduardo Longoria
AstraZeneca’s new blood pressure drug bought from CinCor clears major trial

AstraZeneca’s new blood pressure drug bought from CinCor clears major trial

Joachim Eeckhout
China grabs 32% of global biotech deal value in 2025 surge

China grabs 32% of global biotech deal value in 2025 surge

Joachim Eeckhout
Daily Snap - 15. July 2025

Daily Snap - 15. July 2025

Joachim Eeckhout
Biotech job cuts continue as three more companies slash workforces

Biotech job cuts continue as three more companies slash workforces

Joachim Eeckhout
FDA rejects Capricor’s Duchenne cell therapy, citing lack of proven benefit

FDA rejects Capricor’s Duchenne cell therapy, citing lack of proven benefit

Joachim Eeckhout
Daily Snap - 14. July 2025

Daily Snap - 14. July 2025

Joachim Eeckhout
Renasant Bio launches with $54.5M to tackle rare kidney disease

Renasant Bio launches with $54.5M to tackle rare kidney disease

Joachim Eeckhout
AbbVie pays $700 million upfront for a trispecific antibody from Ichnos Glenmark Innovation

AbbVie pays $700 million upfront for a trispecific antibody from Ichnos Glenmark Innovation

Joachim Eeckhout
Actithera lands $75.5M to chase next-gen cancer radiopharma

Actithera lands $75.5M to chase next-gen cancer radiopharma

Joachim Eeckhout
Merck bets $10B on COPD breakthrough with Verona Pharma buyout

Merck bets $10B on COPD breakthrough with Verona Pharma buyout

Joachim Eeckhout
FirstBack
15161718192021
Next Last